Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange Detected- A new revision entry v3.6.0 has been added to the study history, replacing the previous v3.5.5. This reflects a platform version update to the history view and does not affect trial data.SummaryDifference0.5%

- Check21 days agoChange DetectedA new revision entry v3.5.5 was added to the history, and the previous revision v3.5.4 was removed from the listing.SummaryDifference0.1%

- Check42 days agoChange DetectedNew revision entry Revision: v3.5.4 was added to the study's record history, replacing Revision: v3.5.3. This update reflects a version-history change rather than a substantive modification to the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedUpdate the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**, reflecting a site-level release rather than a modification to the study’s documented information.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.